Business · 12/08/2020
FDA Announces Final Guidance for Developing Drugs for Male Breast Cancer Treatment
The FDA is releasing a final guidance document outlining recommendations for the development and labeling of cancer drugs for male breast cancer patients, aiming to improve treatment options and clinical management.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →